Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes.
Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.
Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.
In vivo vs. ex vivo Magnetic Resonance Imaging In Mice.
Clinical analysis of the etiology of optic neuritis in patients at different ages in china.
Differences in Diffusion Tensor Imaging-Derived Metrics in the Corpus Callosum of Patients With Multiple Sclerosis Without and With Gadolinium-Enhancing Cerebral Lesions.
Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis
Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy.
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Intermittent Atrioventricular Block following Fingolimod Initiation.
The genetic and environmental bases of complex human-disease: extending the utility of twin-studies.
Switching to Gilenya® (fingolimod) from a standard interferon offers sustained freedom from disease activity for people with relapsing remitting multiple sclerosis
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
Dilantin (phenytoin) Supplemental Approval Letter
A case of multiple sclerosis improvement following removal of heavy metal intoxication : Lessons learnt from Matteo's case.
Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
Disclosing the diagnosis of multiple sclerosis: The Profile Project.
Self-management for people with long-term neurological conditions.
New technologies for biomarker discovery in multiple sclerosis.
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.
Central Nervous System and its Disease Models on a Chip.
Modeling the heterogeneity of multiple sclerosis in animals.
Evaluating medically at-risk drivers: a survey of assessment practices in Canada.
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.

Pages